Statera Biopharma, Inc. (STAB)
OTCMKTS: STAB · Delayed Price · USD
0.0006
+0.0001 (20.00%)
Jul 25, 2024, 4:00 PM EDT - Market closed
Statera Biopharma Market Cap
Statera Biopharma has a market cap or net worth of $42.85 thousand as of July 26, 2024. Its market cap has decreased by -99.94% in one year.
Market Cap
42.85K
Enterprise Value
6.94M
1-Year Change
-99.94%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since July 25, 2006, Statera Biopharma's market cap has decreased from $34.80M to $42.85K, a decrease of -99.88%. That is a compound annual growth rate of -33.41%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 11, 2023 | 5.00M | 13.64% |
Dec 30, 2022 | 4.40M | -94.04% |
Dec 31, 2021 | 73.80M | 60.43% |
Dec 31, 2020 | 46.00M | 576.47% |
Dec 31, 2019 | 6.80M | -40.35% |
Dec 31, 2018 | 11.40M | -74.78% |
Dec 29, 2017 | 45.20M | 189.74% |
Dec 30, 2016 | 15.60M | -58.40% |
Dec 31, 2015 | 37.50M | 130.06% |
Dec 31, 2014 | 16.30M | -69.19% |
Dec 31, 2013 | 52.90M | -8.48% |
Dec 31, 2012 | 57.80M | -43.11% |
Dec 30, 2011 | 101.60M | -48.74% |
Dec 31, 2010 | 198.20M | 197.60% |
Dec 31, 2009 | 66.60M | 128.08% |
Dec 31, 2008 | 29.20M | -72.76% |
Dec 31, 2007 | 107.20M | 79.87% |
Dec 29, 2006 | 59.60M | 71.26% |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 780.77B |
Novo Nordisk | 581.75B |
UnitedHealth Group | 515.12B |
Johnson & Johnson | 384.44B |
AbbVie | 321.71B |
Merck & Co. | 318.75B |
AstraZeneca | 243.45B |
Thermo Fisher | 226.95B |